Abstract

Objectives: To investigate the association between obesity and glycemic control based on country-specific glycemic control data from the USA and selected European and Asian countries by body mass index (BMI), or BMI data by glycemic control (HbA1c), in individuals with type 2 diabetes (T2D). Methods: Literature search of databases and abstracts to identify real-world studies (2015-2020) reporting HbA1c and BMI data. Results: Seventeen articles (China, including Hong Kong, n=10; Japan, n=3; USA, n=2; Spain, n=1; UK, n=1) were identified from 6696 de-duplicated references. Of the 13 studies reporting by BMI mean rates of glycemic control or likelihood of achieving glycemic control, eight found that achieving control significantly declined as BMI increased; one reported a clear trend but no statistics; two reported glycemic control rates for those with obesity to be significantly worse than for one other group; and two reported no significant difference with BMI. Of the six studies reporting average HbA1c levels by BMI, four reported HbA1c to increase with BMI. Two of three studies reporting mean BMIs by glycemic control found these increased with HbA1c. Conclusions: This review consolidates recent evidence on the glycemic control status of individuals with T2D reported by BMI in selected countries. Studies generally reported a lower chance of achieving glycemic control targets in those with overweight or obesity. Most studies found greater HbA1c in individuals with higher BMI, and average BMI greater in those with higher levels of HbA1c. Focused efforts are needed to improve glycemic control in patients with T2D and overweight/obesity.

Highlights

  • Type 2 diabetes (T2D) and obesity are intrinsically linked

  • Such guidelines outline that all individuals with T2D and overweight or obesity should be advised of the health benefits of weight loss and be encouraged to engage in a program

  • Database searches yielded 6696 de-duplicated records and after initial abstract and full-text review 17 articles remained for inclusion in the final dataset

Read more

Summary

Introduction

Obesity is a major risk factor for developing T2D, and the progression of disease increases with obesity [1]. Given the close relationship between T2D and obesity, weight reduction is a key therapeutic goal in both the prevention and management of type 2 diabetes [1,6], with weight management playing a prominent role in T2D guidelines. Such guidelines outline that all individuals with T2D and overweight or obesity should be advised of the health benefits of weight loss and be encouraged to engage in a program

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.